Ankle Osteoarthritis: Symptoms, Conservative Treatment, and Surgery Options

Treatment	Mechanism	Evidence	Duration of Effect	Best Candidate
Activity modification + low-impact exercise	Reduces joint load; maintains cartilage nutrition; strengthens periarticular muscles	Strong	Ongoing with continuation	All OA stages; first-line treatment
Custom AFO / ankle brace	Limits end-range ROM; reduces tibiotalar compression force; absorbs shock	Moderate	Ongoing with use	Moderate-severe OA; patients wanting to delay surgery
Custom orthotics	Controls pronation; improves alignment; reduces medial compartment load	Moderate	Ongoing with use	OA with malalignment; flat foot loading pattern
Cortisone injection	Anti-inflammatory; reduces synovial inflammation	Moderate; short-term relief	4–12 weeks per injection; max 3–4/year	Flares; moderate OA; bridging to surgery or other treatment
Hyaluronic acid injection (viscosupplementation)	Lubricates joint; anti-inflammatory; may stimulate proteoglycan production	Moderate (ankle-specific data limited)	3–6 months per course	Moderate OA; failed cortisone; not surgical candidates
PRP (platelet-rich plasma)	Growth factor delivery; anti-inflammatory; cartilage protection	Emerging; promising ankle-specific data	6–12 months per injection	Mild-moderate OA; active patients; alternative to cortisone
Ankle arthroscopy (debridement)	Removes loose bodies; trims impinging osteophytes; joint washout	Moderate for anterior impingement; limited for diffuse OA	Variable; 1–3 years	Anterior impingement; OA with mechanical symptoms (catching, locking)
Supramalleolar osteotomy	Realigns tibiotalar axis; shifts load from damaged to preserved cartilage	Good for varus/valgus malalignment OA	5–10 years before further surgery needed in many	Younger patients; significant malalignment; focal compartment OA
Total ankle replacement (TAR)	Resurfaces tibiotalar joint; preserves motion	Strong; 10-year survivorship 80–90% modern implants	10–20 years; revision possible	End-stage OA; >55 years old; lower demand; adequate bone stock
Ankle arthrodesis (fusion)	Eliminates tibiotalar motion; eliminates pain from that source	Excellent pain relief; gold standard for end-stage OA	Permanent if successful fusion	End-stage OA; failed TAR; younger high-demand patients; infection risk

Feature	Ankle OA	Knee OA
Primary vs. post-traumatic	70–80% post-traumatic (prior ankle fracture or instability); primary OA uncommon	Primary OA predominant (>80%)
Average age at presentation	55–65 (younger than knee due to trauma history)	65–75
Cartilage thickness	1.0–1.7mm (thinner); higher contact stress per unit area	2.0–3.0mm (thicker)
Conservative treatment success	Good; most patients manage for years with bracing, injections, activity modification	Good; similar conservative options
Surgical options	Arthrodesis (fusion) historically dominant; TAR increasingly used	TKR dominant; fusion reserved for failed TKR or infection
Gait impact of surgery	Fusion eliminates tibiotalar motion; compensatory subtalar motion; altered gait pattern	TKR preserves motion; near-normal gait possible

What Is Ankle Osteoarthritis?

Ankle osteoarthritis is progressive degradation of the cartilage in the tibiotalar joint — the joint between the tibia and the talus that allows the foot to move up and down. Unlike knee and hip OA, which are predominantly primary (arising without a specific prior injury), ankle OA is post-traumatic in approximately 70–80% of cases: it develops years to decades after ankle fractures, chronic ligamentous instability, or osteochondral lesions that created abnormal loading patterns and accelerated cartilage wear. This is why ankle OA tends to present in patients in their 50s and 60s — often younger than those with primary knee or hip OA — with a history of ankle injury 10–20 years prior.

Symptoms and Diagnosis

Ankle OA presents with deep aching joint pain that worsens with weight-bearing activity and improves with rest, morning stiffness lasting less than 30 minutes (longer stiffness suggests inflammatory arthritis), progressive loss of dorsiflexion and plantarflexion range of motion, and swelling of the ankle joint. A hallmark finding is the “start-up pain” that is worst with the first steps in the morning or after prolonged sitting, then improves with movement as the joint warms up. X-rays confirm the diagnosis: joint space narrowing, osteophyte formation (bone spurs at the joint margins), subchondral sclerosis, and eventually joint surface irregularity. MRI is used when extent of cartilage damage needs better characterization or to evaluate for osteochondral lesions.

Conservative Management: What Works and for How Long

Most ankle OA patients are managed conservatively for years. Activity modification — replacing high-impact activities (running, basketball) with low-impact alternatives (cycling, swimming, elliptical) — maintains cardiovascular fitness while dramatically reducing tibiotalar joint stress. An ankle brace or custom AFO limits end-range motion (which is where impinging osteophytes cause pain), absorbs shock, and reduces the need for pain medication. Custom orthotics correct the malalignment patterns (excess pronation or supination) that accelerate asymmetric cartilage wear. Cortisone injections provide 4–12 weeks of anti-inflammatory relief and are useful for managing flares or bridging to other treatment. Repeat cortisone more than 3–4 times per year should be avoided due to risk of cartilage degradation and tendon weakening.

Surgery: Fusion vs. Replacement

When conservative management no longer controls pain and quality of life is significantly affected, two surgical options address end-stage ankle OA: ankle arthrodesis (fusion) and total ankle replacement (TAR). Ankle fusion eliminates tibiotalar motion, eliminating pain from that source. The ankle is locked in a neutral position; walking is possible because the subtalar and midtarsal joints compensate for some motion, though gait is altered. Fusion is durable and appropriate for younger, higher-demand patients and those with significant bone defects or prior infection. Total ankle replacement resurfaces the joint with a three-component implant, preserving motion. Modern third-generation implants have 10-year survivorship of 80–90%. TAR is preferred for lower-demand patients over 55 with adequate bone stock and without significant malalignment. The choice between fusion and replacement is determined by patient age, activity level, bone quality, and the surgeon’s experience — both provide excellent pain relief in appropriately selected patients.

At Balance Foot & Ankle, Dr. Tom Biernacki and Dr. Carl Jay provide ankle osteoarthritis evaluation, injection therapy, orthotics, and surgical management at both the Howell and Bloomfield Hills offices. Call (810) 206-1402.

For a complete clinical overview: Ankle Pain Conditions Guide — location-by-location ankle pain diagnosis and treatment